Amniocytes can serve a dual function as a source of iPS cells and feeder layers

Human Molecular Genetics

Volumn 20, Issue 5, 2011, Pages 962-974

  Anchan, Raymond M ^a   Quaas, Philipp ^a   Gerami Naini, Behzad ^a   Bartake, Hrishikesh ^a   Griffin, Adam ^a   Zhou, Yilan ^a   Day, Daniel ^b   Eaton, Jennifer L ^a   George, Liji L ^a   Naber, Catherine ^a   Turbe Doan, Annick ^a   Park, Peter J ^a,c   Hornstein, Mark D ^a   Maas, Richard L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 4; STEM CELL FACTOR;

AMNION CELL; AMNIOTIC FLUID CELL; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL FUNCTION; CELL POPULATION; DNA METHYLATION; ECTODERM; EMBRYO; EMBRYOID BODY; EMBRYONIC STEM CELL; ENDODERM; FEMALE; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MESODERM; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TERATOMA;

AMNION; ANIMALS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELLS, CULTURED; EMBRYONIC STEM CELLS; FEMALE; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICE; MICE, INBRED C57BL; OCTAMER TRANSCRIPTION FACTORS;

IPS;

EID: 79551613920     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddq542     Document Type: Article

References (54)

1. Halme, D.G. and Kessler, D.A. (2006) FDA regulation of stem-cell-based therapies. N. Engl. J. Med., 355, 1730-1735.
2. FDA. (2001). PHS Guideline on Infectious Disease Issues in Xenotransplantation, from http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Xenotransplantation/ucm074727.htm.
3. Yu, J., Vodyanik, M.A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J.L., Tian, S., Nie, J., Jonsdottir, G.A., Ruotti, V., Stewart, R. et al. (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science, 318, 1917-1920.
4. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K. and Yamanaka, S. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131, 861-872.
5. Okita, K., Nakagawa, M., Hyenjong, H., Ichisaka, T. and Yamanaka, S. (2008) Generation of mouse induced pluripotent stem cells without viral vectors. Science, 322, 949-953.
6. Stadtfeld, M., Nagaya, M., Utikal, J., Weir, G. and Hochedlinger, K. (2008) Induced pluripotent stem cells generated without viral integration. Science, 322, 945-949.
7. Yu, J., Hu, K., Smuga-Otto, K., Tian, S., Stewart, R., Slukvin, I.I. and Thomson, J.A. (2009) Human induced pluripotent stem cells free of vector and transgene sequences. Science, 324, 797-801.
8. Zhou, H., Wu, S., Joo, J.Y., Zhu, S., Han, D.W., Lin, T., Trauger, S., Bien, G., Yao, S., Zhu, Y. et al. (2009) Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell, 4, 381-384.
9. Kim, D., Kim, C.H., Moon, J.I., Chung, Y.G., Chang, M.Y., Han, B.S., Ko, S., Yang, E., Cha, K.Y., Lanza, R. et al. (2009) Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell, 4, 472-476.
10. Huangfu, D., Osafune, K., Maehr, R., Guo, W., Eijkelenboom, A., Chen, S., Muhlestein, W. and Melton, D.A. (2008) Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat. Biotechnol., 26, 1269-1275.
11. Lyssiotis, C.A., Foreman, R.K., Staerk, J., Garcia, M., Mathur, D., Markoulaki, S., Hanna, J., Lairson, L.L., Charette, B.D., Bouchez, L.C. et al. (2009) Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4. Proc. Natl Acad. Sci. USA, 106, 8912-8917.
12. Li, W., Wei, W., Zhu, S., Zhu, J., Shi, Y., Lin, T., Hao, E., Hayek, A., Deng, H. and Ding, S. (2009) Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors. Cell Stem Cell, 4, 16-19.
13. Warren, L., Manos, P.D., Ahfeldt, T., Loh, Y.H., Li, H., Lau, F., Ebina, W., Mandal, P.K., Smith, Z.D., Meissner, A. et al. (2010) Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell, 7, 618-630.
14. Takahashi, K. and Yamanaka, S. (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126, 663-676.
15. Chin, M.H., Mason, M.J., Xie, W., Volinia, S., Singer, M., Peterson, C., Ambartsumyan, G., Aimiuwu, O., Richter, L., Zhang, J. et al. (2009) Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell, 5, 111-123.
16. Wernig, M., Zhao, J.P., Pruszak, J., Hedlund, E., Fu, D., Soldner, F., Broccoli, V., Constantine-Paton, M., Isacson, O. and Jaenisch, R. (2008) Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc. Natl Acad. Sci. USA, 105, 5856-5861.
17. Soldner, F., Hockemeyer, D., Beard, C., Gao, Q., Bell, G.W., Cook, E.G., Hargus, G., Blak, A., Cooper, O., Mitalipova, M. et al. (2009) Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell, 136, 964-977.
18. Park, I.H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M.W., Cowan, C., Hochedlinger, K. and Daley, G.Q. (2008) Disease-specific induced pluripotent stem cells. Cell, 134, 877-886.
19. Dimos, J.T., Rodolfa, K.T., Niakan, K.K., Weisenthal, L.M., Mitsumoto, H., Chung, W., Croft, G.F., Saphier, G., Leibel, R., Goland, R. et al. (2008) Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science, 321, 1218-1221.
20. Aasen, T., Raya, A., Barrero, M.J., Garreta, E., Consiglio, A., Gonzalez, F., Vassena, R., Bilic, J., Pekarik, V., Tiscornia, G. et al. (2008) Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat. Biotechnol., 26, 1276-1284.
21. Park, I.H., Zhao, R., West, J.A., Yabuuchi, A., Huo, H., Ince, T.A., Lerou, P.H., Lensch, M.W. and Daley, G.Q. (2008) Reprogramming of human somatic cells to pluripotency with defined factors. Nature, 451, 141-146.
22. Meissner, A., Wernig, M. and Jaenisch, R. (2007) Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat. Biotechnol., 25, 1177-1181.
23. Loh, Y.H., Agarwal, S., Park, I.H., Urbach, A., Huo, H., Heffner, G.C., Kim, K., Miller, J.D., Ng, K. and Daley, G.Q. (2009) Generation of induced pluripotent stem cells from human blood. Blood, 113, 5476-5479.
24. Aoi, T., Yae, K., Nakagawa, M., Ichisaka, T., Okita, K., Takahashi, K., Chiba, T. and Yamanaka, S. (2008) Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science, 321, 699-702.
25. Lowry, W.E., Richter, L., Yachechko, R., Pyle, A.D., Tchieu, J., Sridharan, R., Clark, A.T. and Plath, K. (2008) Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc. Natl Acad. Sci. USA, 105, 2883-2888.
26. Sun, N., Panetta, N.J., Gupta, D.M., Wilson, K.D., Lee, A., Jia, F., Hu, S., Cherry, A.M., Robbins, R.C., Longaker, M.T. et al. (2009) Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc. Natl Acad. Sci. USA, 106, 15720-15725.
27. Eminli, S., Foudi, A., Stadtfeld, M., Maherali, N., Ahfeldt, T., Mostoslavsky, G., Hock, H. and Hochedlinger, K. (2009) Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells. Nat. Genet., 41, 968-976.
28. Turner, C.G. and Fauza, D.O. (2009) Fetal tissue engineering. Clin. Perinatol., 36, 473-488, xii.
29. Delo, D.M., De Coppi, P., Bartsch, G. Jr and Atala, A. (2006) Amniotic fluid and placental stem cells. Methods Enzymol., 419, 426-438.
30. De Coppi, P., Bartsch, G. Jr, Siddiqui, M.M., Xu, T., Santos, C.C., Perin, L., Mostoslavsky, G., Serre, A.C., Snyder, E.Y., Yoo, J.J. et al. (2007) Isolation of amniotic stem cell lines with potential for therapy. Nat. Biotechnol., 25, 100-106.
31. Steigman, S.A. and Fauza, D.O. (2007) Isolation of mesenchymal stem cells from amniotic fluid and placenta. Curr. Protoc. Stem Cell Biol., Chapter 1, Unit 1E 2.
32. Perin, L., Sedrakyan, S., Giuliani, S., Da Sacco, S., Carraro, G., Shiri, L., Lemley, K.V., Rosol, M., Wu, S., Atala, A. et al. (2010) Protective effect of human amniotic fluid stem cells in an immunodeficient mouse model of acute tubular necrosis. PLoS ONE, 5, e9357.
33. Sun, H., Feng, K., Hu, J., Soker, S., Atala, A. and Ma, P.X. (2009) Osteogenic differentiation of human amniotic fluid-derived stem cells induced by bone morphogenetic protein-7 and enhanced by nanofibrous scaffolds. Biomaterials, 31, 1133-1139.
34. Li, C., Zhou, J., Shi, G., Ma, Y., Yang, Y., Gu, J., Yu, H., Jin, S., Wei, Z., Chen, F. et al. (2009) Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells. Hum. Mol. Genet., 18, 4340-4349.
35. Galende, E., Karakikes, I., Edelmann, L., Desnick, R.J., Kerenyi, T., Khoueiry, G., Lafferty, J., McGinn, J.T., Brodman, M., Fuster, V. et al. (2010) Amniotic fluid cells are more efficiently reprogrammed to pluripotency than adult cells. Cell Reprogram, 12, 117-125.
36. Olney, R.S., Moore, C.A., Khoury, M.J., Erickson, J.D., Edmonds, L.D., Botto, L.D. and Atrash, H.K. (1995) Centers for disease control and prevention. Chorionic villus sampling and amniocentesis: recommendations for prenatal counseling. MMWR, 44, 1-12.
37. Chin, A.C., Padmanabhan, J., Oh, S.K. and Choo, A.B. (2009) Defined and serum-free media support undifferentiated human embryonic stem cell growth. Stem Cells Dev., 19, 753-761.
38. FDA. (2002). Information and Recommendations for Physicians Involved in the Co-Culture of Human Embryos with Non-Human Animal Cells, from http://www.fda.gov/BiologicsBloodVaccines/Xenotransplantation/ucm136532.htm.
39. FDA. (2002). Human Cells or Tissues Intended for Transplant into a Human Recipient that Have Ex-vivo Contact with Live Non-human Animal Cells, Tissues or Organs Letter, from http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/ucm136703.htm.
40. Beattie, G.M., Lopez, A.D., Bucay, N., Hinton, A., Firpo, M.T., King, C.C. and Hayek, A. (2005) Activin A maintains pluripotency of human embryonic stem cells in the absence of feeder layers. Stem Cells, 23, 489-495.
41. Ludwig, T.E., Bergendahl, V., Levenstein, M.E., Yu, J., Probasco, M.D. and Thomson, J.A. (2006) Feeder-independent culture of human embryonic stem cells. Nat. Methods, 3, 637-646.
42. Draper, J.S., Smith, K., Gokhale, P., Moore, H.D., Maltby, E., Johnson, J., Meisner, L., Zwaka, T.P., Thomson, J.A. and Andrews, P.W. (2004) Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat. Biotechnol., 22, 53-54.
43. Catalina, P., Montes, R., Ligero, G., Sanchez, L., de la Cueva, T., Bueno, C., Leone, P.E. and Menendez, P. (2008) Human ESCs predisposition to karyotypic instability: is a matter of culture adaptation or differential vulnerability among hESC lines due to inherent properties? Mol. Cancer, 7, 76.
44. Takahashi, K., Narita, M., Yokura, M., Ichisaka, T. and Yamanaka, S. (2009) Human induced pluripotent stem cells on autologous feeders. PLoS ONE, 4, e8067.
45. Maherali, N., Ahfeldt, T., Rigamonti, A., Utikal, J., Cowan, C. and Hochedlinger, K. (2008) A high-efficiency system for the generation and study of human induced pluripotent stem cells. Cell Stem Cell, 3, 340-345.
46. Ji, H., Ehrlich, L.I., Seita, J., Murakami, P., Doi, A., Lindau, P., Lee, H., Aryee, M.J., Irizarry, R.A., Kim, K. et al. (2010) Comprehensive methylome map of lineage commitment from haematopoietic progenitors. Nature, 467, 338-342.
47. Kim, K., Doi, A., Wen, B., Ng, K., Zhao, R., Cahan, P., Kim, J., Aryee, M.J., Ji, H., Ehrlich, L.I. et al. (2010) Epigenetic memory in induced pluripotent stem cells. Nature, 467, 285-290.
48. Polo, J.M., Liu, S., Figueroa, M.E., Kulalert, W., Eminli, S., Tan, K.Y., Apostolou, E., Stadtfeld, M., Li, Y., Shioda, T. et al. (2010) Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat. Biotechnol., 28, 848-855.
49. Lee, A.S., Tang, C., Cao, F., Xie, X., van der Bogt, K., Hwang, A., Connolly, A.J., Robbins, R.C. and Wu, J.C. (2009) Effects of cell number on teratoma formation by human embryonic stem cells. Cell Cycle, 8, 2608-2612.
50. Lengner, C.J., Camargo, F.D., Hochedlinger, K., Welstead, G.G., Zaidi, S., Gokhale, S., Scholer, H.R., Tomilin, A. and Jaenisch, R. (2007) Oct4 expression is not required for mouse somatic stem cell self-renewal. Cell Stem Cell, 1, 403-415.
51. Evans, M.J. and Kaufman, M.H. (1981) Establishment in culture of pluripotential cells from mouse embryos. Nature, 292, 154-156.
52. Takahashi, K., Okita, K., Nakagawa, M. and Yamanaka, S. (2007) Induction of pluripotent stem cells from fibroblast cultures. Nat. Protoc., 2, 3081-3089.
53. Thomson, J.A., Itskovitz-Eldor, J., Shapiro, S.S., Waknitz, M.A., Swiergiel, J.J., Marshall, V.S. and Jones, J.M. (1998) Embryonic stem cell lines derived from human blastocysts. Science, 282, 1145-1147.
54. Osakada, F., Ikeda, H., Sasai, Y. and Takahashi, M. (2009) Stepwise differentiation of pluripotent stem cells into retinal cells. Nat. Protoc., 4, 811-824.